drugset / Trial / NCT07279636
A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of Alpha-0261 tablets after single oral administration in healthy adult volunteers.
Timeline
- Start
- 2025-07-21
- Primary completion
- 2026-02-14
- Completion
- 2026-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alpha-0261 | Unknown | — | Oral |
Indications
No indication recorded.